Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $1.89 Analyst target: $25.00 Upside: 1222.75%
Processa Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of pharmaceutical products for the treatment of patients with unmet medical needs in the United States. The company is headquartered in Hanover, Maryland.
See the full interactive analysis & chart →Informational only — not investment advice.